---
figid: PMC9646457__cjcr-34-5-460-5
figtitle: Myeloid checkpoints for cancer immunotherapy
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9646457
filename: cjcr-34-5-460-5.jpg
figlink: /pmc/articles/PMC9646457/figure/Figure5/
number: F5
caption: Role of PD-1/PD-L1. PD-1-expressing macrophages exhibit an anti- inflammatory-like
  surface profile in tumor settings. PD-1 expression is negatively correlated to phagocytic
  ability of macrophages. PD-L1 antibody treatment promotes cell proliferation of
  cultured bone marrow-derived macrophages, which is related to the activation of
  the AKT-mTOR pathway. PD-1, programmed cell death 1; PD-L1, programmed cell death
  ligand 1.
papertitle: Myeloid checkpoints for cancer immunotherapy.
reftext: Yixin Qian, et al. Chin J Cancer Res. 2022 Oct 30;34(5):460-482.
year: '2022'
doi: 10.21147/j.issn.1000-9604.2022.05.07
journal_title: Chinese Journal of Cancer Research
journal_nlm_ta: Chin J Cancer Res
publisher_name: AME Publishing Company
keywords: Cancer | immune checkpoint | myeloid checkpoint | MDSC | TAM | immunotherapy
automl_pathway: 0.9678156
figid_alias: PMC9646457__F5
figtype: Figure
redirect_from: /figures/PMC9646457__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9646457__cjcr-34-5-460-5.html
  '@type': Dataset
  description: Role of PD-1/PD-L1. PD-1-expressing macrophages exhibit an anti- inflammatory-like
    surface profile in tumor settings. PD-1 expression is negatively correlated to
    phagocytic ability of macrophages. PD-L1 antibody treatment promotes cell proliferation
    of cultured bone marrow-derived macrophages, which is related to the activation
    of the AKT-mTOR pathway. PD-1, programmed cell death 1; PD-L1, programmed cell
    death ligand 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD274
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - tumor
---
